Cameron Turtle - Chief Executive Officer, Director at Spyre Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chief Executive Officer, Director
- Issuer Symbol
- SYRE on Nasdaq
- All Insider Reports
- All Insider Reports
Cameron Turtle - trading volume in the past year for Spyre Therapeutics, Inc.
| Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|
| Buys | ||||
| Sells | -120,000 | 100% | $31.75 | -$3,810,091 |
| Net | -120,000 | -100% | -$3,810,091 |
Holdings reported by Cameron Turtle for Spyre Therapeutics, Inc.
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 627,540 | $31,326,796 | $49.92 | 01 Apr 2026 | Direct | ||
| Stock Option (Right to Buy) | 528,000 | 09 Jan 2026 | Direct | Common Stock |
Transactions reported by Cameron Turtle for Spyre Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.